CBI Scene Blog

What if Vendors Created Their Own TransCelerate?

Posted by Amy Ripston on Nov 22, 2013 3:53:00 PM

teamwork resized 600

TransCelerate is definitely shaking things up in the bio/pharma industry. Who would have thought only a few years ago that the largest biotechs and pharmas organizations would form a pre-competitive alliance to address some of the core challenges, lower costs and increase efficiencies? Its successes are just beginning, but one thing is certain – It’s posing some new challenges for the vendor community.

One might be tempted to ask, did the idea of an industry coalition gain traction because these offerings were not available in the marketplace? Was the idea of solving common challenges together so novel that the market had not yet tapped into this? Whatever the case, it’s clear this opportunity has the attention of the marketplace now!    

At CBI’s recent Clinical IVR/IWR conference, I had the pleasure of engaging with Amy Black, Associate Director, eClinical Business Solutions at Onyx Pharmaceuticals on the topic of TransCelerate and innovation in clinical technology. “Innovation can mean so many things to so many people, the real question is why is the pharma marketplace not modeling what’s happening in Silicon Valley and translating it to pharma? Why are we only now beginning to capitalize on cloud and mobile technology? What is the latest technology that we should be looking towards to better serve our patients’ needs?” says Black. As we continued the discussion of innovation and vendor offerings in the marketplace, these questions arose:

What if vendors created their own TransCelerate?

What would it look like? 

What common services can vendors innovate and provide together to sponsors?

How could vendors capitalize on the innovative principles of TransCelerate and truly understand the needs of the industry?

I don’t have a crystal ball, but the picture would be fascinating if the vendor community could put aside competition and challenge themselves on a few fronts: 

  • How can marketplace bring true innovation to the industry and proactively meet the needs of the evolving clinical landscape?
  • Pay attention to the TransCelerate movement – what can you do collaboratively with your competitors that seemed impossible two years ago? 
  • Think outside of the box – what’s on the cutting edge in Silicon Valley that you might be able to leverage for the pharma industry?

Want to hear more about how clinical technologies are evolving to meet the demands of future R&D projects? Mark your calendar for ClinTech 2014, March 11-13, 2014, and hear Amy Black pose these questions and more. Click on the button below to receive more information about this event!

Clintech 2014


(Image courtesy of Port of San Diego via Flickr)

Amy Black is the Associate Director for eClinical Business Solutions at Onyx Pharmaceuticals. She has led large-scale, cross-functional clinical systems implementations and integrations for the past decade, focusing on building business capability through processes and standards. As the former Global Business Manager for the Roche Clinical Trial Administration Systems, she has deep experience in driving business value through system optimization and operational management, project management and strategic change communications. Ms. Black is based on South San Francisco.

Topics: Clinical